HHS Humana Sues HHS Over Medicare Advantage Audit Final Rule Thomas Sullivan Nov 2, 2023 0 Humana is suing the United States Department of Health and Human Services (HHS) over the plan to audit Medicare Advantage…
Congress House Subcommittee on Health Discusses Many Bills that Could Help Seniors… Thomas Sullivan Nov 1, 2023 0 The United States House of Representatives Energy and Commerce Committee Subcommittee on Health recently held a hearing,…
Innovation Artificial Intelligence in the Health Care Industry – Current Trends Thomas Sullivan Oct 31, 2023 0 Artificial intelligence – or AI – is a popular buzzword right now. But what does it mean for the health care industry? While it…
FTC FTC Reaches Anti-Trust Settlement with Surescripts Thomas Sullivan Oct 30, 2023 0 Recently, the United States Federal Trade Commission (FTC) announced a settlement with Surescripts over the company’s alleged use…
CME 2023 PCE Oncology Fall Conferences: An Essential Learning Opportunity for… Thomas Sullivan Oct 28, 2023 0 In the ever-evolving field of oncology, staying up to date with the latest advancements and best practices is crucial for…
CMS CMS Announces New Slate of Reduced Coinsurance Drugs for Q4 2023 Thomas Sullivan Oct 27, 2023 0 Recently, the Centers for Medicare and Medicaid Services (CMS) announced a third set of Medicare Part B prescription drugs that…
Editorials The Importance of Intellectual Property Protections for Patients Thomas Sullivan Oct 27, 2023 0 Patent protections for new drugs have ignited an unparalleled surge of innovation, significantly benefiting patients, and should…
Congress Legislation Introduced to Enhance Value-Based Purchasing Arrangements in… Thomas Sullivan Oct 26, 2023 0 A bipartisan group of United States Representatives introduced the Medicaid VBPs for Patients (MVP) Act of 2023 to further enhance…
Telemedicine Telemedicine Leads to Fewer Follow-Up Visits When Compared to In-Person… Thomas Sullivan Oct 25, 2023 0 Recently, Epic published research that found that telehealth patients are often less likely to attend follow-up visits, when…
FDA FDA Releases Draft Guidance on Unapproved Use Communications from Firms to… Thomas Sullivan Oct 24, 2023 0 Recently, the United States Food and Drug Administration (FDA) released a draft guidance document, Communications from Firms to…